Juliette Lambert, MD, Versailles Hospital, Le Chesnay, France, talks on treatment options for acute myeloid leukemia (AML), including gemtuzumab ozogamicin. Dr Lambert highlights the importance of finding the place for gemtuzumab ozogamicin among targeted therapies. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).